Marché mondial de l’aminophylline – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et taille du marché de l'aminophylline

Le marché de l'aminophylline devrait connaître une croissance significative au cours de la période de prévision. Les maladies respiratoires étant l'une des principales causes de décès selon l'OMS, les médicaments à base d'aminophylline aident à diagnostiquer la population atteinte de ces troubles. De plus, l'innovation rapide dans les médicaments personnalisés avec les avancées technologiques propulsera également le marché de l'aminophylline.

Data Bridge Market Research analyse le taux de croissance du marché de l'aminophylline au cours de la période de prévision 2022-2029. Le TCAC attendu du marché de l'aminophylline a tendance à être d'environ 2,50 % au cours de la période de prévision mentionnée. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe Data Bridge Market Research comprend également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Définition du marché

L'aminophylline est un sel d'éthylènediamine de la théophylline. Après la prise d'aminophylline, la théophylline est libérée. L'aminophylline détend les muscles lisses des voies respiratoires bronchiques et des vaisseaux sanguins pulmonaires et diminue la réactivité des voies respiratoires à l'histamine, à la méthacholine, à l'adénosine et aux allergènes. Elle agit comme un inhibiteur de la phosphodiestérase, un bloqueur des récepteurs de l'adénosine et un activateur de l'histone désacétylase.  

Portée et segmentation du marché de l'aminophylline

Global Aminophylline Market Dynamics

Drivers

• Increase in COPD cases

According to WHO, COPD mainly occurs in the underdeveloped countries. In addition to this, a study conducted in 2016 reported 251 million cases of COPD worldwide. Chronic obstructive pulmonary disease is categorized by the symptoms such as shortness of breath, wheezing, frequent coughing, and tightness in the chest. This boost the market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Increasing Drug Development and Research Activities

Technological advancements and rapid drug discovery and development innovation, especially in personalized medicine, create significant opportunities for manufacturers in the global aminophylline market. This is another factor expected to drive growth of the aminophylline market.  

• Increasing Demand for Retail Pharmacies

The rise in the number of drugs being delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Side Effects of Aminophylline

There are varied side-effects that are associated with aminophylline. Side-effects such as nausea, increased gastric acid secretion, vomiting, polyuria, insomnia, headaches, palpitations, and tremors may hamper the growth of the market.

• High Cost

The huge expenditure associated with these agents hamper the market growth. Different types of aminophyllines are costing high and are hampering the growth of the market.

This global aminophylline market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global aminophylline market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Aminophylline Market             

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period. The transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.

In the post-pandemic era, the biotechnology and pharmaceutical industries are expected to witness a huge future growth due to the demand for vaccines and treatment drugs for COVID-19. Thus, this will leave a significant impact on the global aminophylline market.

Global Aminophylline Market Scope

The global aminophylline market is segmented on the basis of indications, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indications

• Bronchospasm
• Asthma
• Emphysema
• Chronic Bronchitis
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Aminophylline Market Regional Analysis/Insights

The aminophylline market is analyzed and market size insights and trends are provided by indications, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the aminophylline market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing positive growth for aminophylline market  throughout the forecasted period due to the increased presence of generic manufacturers and the increasing geriatric population.

North America dominates the market due to the presence of key manufacturers of the product, high research & development, and healthcare expenditure and skilled professionals.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Analyse du paysage concurrentiel et des parts de marché mondiales de l'aminophylline

Le paysage concurrentiel du marché mondial de l'aminophylline fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché mondial de l'aminophylline

Les principaux acteurs opérant sur le marché mondial de l'aminophylline comprennent :

• Bayer AG (Allemagne)
• Teva Pharmaceutical Industries Ltd. (Israël)
• Sun Pharmaceutical Industries Ltd. (Inde)
• Hikma Pharmaceutical PLC (Royaume-Uni)
• Amneal Pharmaceuticals LLC. (États-Unis)
• Aurobindo Pharma (Inde)
• Johnsons & Johnsons Private Limited (États-Unis)
• Actiza Pharmaceutical Private Limited (Inde)
• TORQUE PHARMACEUTICALS PVT. LTD (Inde)
• Octapharma AG (Suisse)

SKU-55128